FDAnews
www.fdanews.com/articles/148999-new-england-journal-of-medicine-publishes-fame-ii-trial-results-revealing-better-patient-outcomes-with-ffr-guided-cardiac-stenting

New England Journal of Medicine Publishes FAME II Trial Results Revealing Better Patient Outcomes With FFR-Guided Cardiac Stenting

August 28, 2012
St. Jude Medical, Inc., a global medical device company, today announced results of the FAME II Trial demonstrating that patients with FFR-guided stenting plus the best available medical therapy had superior outcomes to those treated with medical therapy alone.
heraldonline.com